-
Mashup Score: 2A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA... by Carsten Müller-Tidow - 1 year(s) ago
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event Platform powered by MULTILEARNING LMS.
Source: library.ehaweb.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA... by Carsten Müller-Tidow - 1 year(s) ago
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event Platform powered by MULTILEARNING LMS.
Source: library.ehaweb.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RCT Plasma From Convalescent & Vaccinated Donors (#COVID19CP) Improves Outcome of #COVID19 Pts with Hematological Disease, Cancer or Immunosuppression [May 12, 2022] Carsten Müller-Tidow et al. Abst S282 #EHA2022 https://t.co/4TMiWXBPM0 #COVID19nCancer HT @DrJPHenderson
-
-
Mashup Score: 2A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA... by Carsten Müller-Tidow - 1 year(s) ago
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event Platform powered by MULTILEARNING LMS.
Source: library.ehaweb.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RCT Plasma From Convalescent & Vaccinated Donors (#COVID19CP) Improves Outcome of #COVID19 Pts with Hematological Disease, Cancer or Immunosuppression [May 12, 2022] Carsten Müller-Tidow et al. Abst S282 #EHA2022 https://t.co/4TMiWXCnBy #COVID19nCancer HT @DrJPHenderson
-
-
Mashup Score: 2A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA... by Carsten Müller-Tidow - 1 year(s) ago
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event Platform powered by MULTILEARNING LMS.
Source: library.ehaweb.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RCT Plasma From Convalescent & Vaccinated Donors (#COVID19CP) Improves Outcome of #COVID19 Pts with Hematological Disease, Cancer or Immunosuppression [May 12, 2022] Carsten Müller-Tidow et al. Abst S282 #EHA2022 https://t.co/4TMiWXBPM0 #COVID19nCancer HT @DrJPHenderson https://t.co/bhT4fiCjHa
-
-
Mashup Score: 0A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA... by Carsten Müller-Tidow - 1 year(s) ago
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event Platform powered by MULTILEARNING LMS.
Source: library.ehaweb.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RCT Plasma From Convalescent & Vaccinated Donors (#COVID19CP) Improves Outcome of #COVID19 Pts with Hematological Disease, Cancer or Immunosuppression [May 12, 2022] Carsten Müller-Tidow et al. Abst S282 #EHA2022 https://t.co/4TMiWXCnBy #COVID19nCancer HT @DrJPHenderson https://t.co/viEEnBGI8L
-
-
Mashup Score: 0A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA... by Carsten Müller-Tidow - 1 year(s) ago
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event Platform powered by MULTILEARNING LMS.
Source: library.ehaweb.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RCT Plasma From Convalescent & Vaccinated Donors (#COVID19CP) Improves Outcome of #COVID19 Pts with Hematological Disease, Cancer or Immunosuppression [May 12, 2022] Carsten Müller-Tidow et al. Abst S282 #EHA2022 https://t.co/4TMiWXkenq #COVID19nCancer HT @DrJPHenderson https://t.co/YWedXToWfG
-
-
Mashup Score: 0A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA... by Carsten Müller-Tidow - 1 year(s) ago
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event Platform powered by MULTILEARNING LMS.
Source: library.ehaweb.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RCT Plasma From Convalescent & Vaccinated Donors (#COVID19CP) Improves Outcome of #COVID19 Pts with Hematological Disease, Cancer or Immunosuppression [May 12, 2022] Carsten Müller-Tidow et al. Abst S282 #EHA2022 https://t.co/4TMiWXkenq #COVID19nCancer HT @DrJPHenderson https://t.co/7E3GJmWgAt
-
-
Mashup Score: 0A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA... by Carsten Müller-Tidow - 1 year(s) ago
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event Platform powered by MULTILEARNING LMS.
Source: library.ehaweb.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RCT Plasma From Convalescent & Vaccinated Donors (#COVID19CP) Improves Outcome of #COVID19 Pts with Hematological Disease, Cancer or Immunosuppression [May 12, 2022] Carsten Müller-Tidow et al. Abst S282 #EHA2022 https://t.co/4TMiWXBPM0 #COVID19nCancer HT @DrJPHenderson https://t.co/Gz8jQuz7Al
-
-
Mashup Score: 0Latest updates in Advanced Systemic Mastocytosis from EHA 2022 - 1 year(s) ago
Latest updates in Advanced Systemic Mastocytosis from EHA 2022. Targeting systemic mastocytosis. Update in Haematology session EHA 2022…
Source: European Medical JournalCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Latest updates in Advanced Systemic Mastocytosis from EHA 2022. Watch now! https://t.co/EY7ZGsA36f #EHA2022 #systemicmastocytosis #haematology
-
-
Mashup Score: 1Visual abstract | QuANTUM-First trial of quizartinib with standard chemotherapy and as continuation therapy in newly diagnosed FLT3-ITD+ AML - 2 year(s) ago
The AML Hub is happy to present a Visual Abstract summarizing key data from the phase III QuANTUM-First trial, evaluating the addition of quizartinib vs placebo to standard chemotherapy and up to three years of continuation therapy in adults aged 18–75 with newly diagnosed FLT3-ITD+ acute myeloid leukemia (AML).
Source: aml-hub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📚Weekend Re-read: Take a look at the first results from the phase III QuANTUM-First trial and the OS in adults aged 18–75 with newly diagnosed FLT3-ITD+ #AML. https://t.co/1jqIONZ3LE #AMLsm #leusm #EHA2022 https://t.co/b0P3rHHOno
-
RCT Plasma From Convalescent & Vaccinated Donors (#COVID19CP) Improves Outcome of #COVID19 Pts with Hematological Disease, Cancer or Immunosuppression [May 12, 2022] Carsten Müller-Tidow et al. Abst S282 #EHA2022 https://t.co/4TMiWXBPM0 #COVID19nCancer HT @DrJPHenderson https://t.co/0WfAm29bUl